tm logo
OXRESA
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 14 Dec 2024

Last Applicant/ Owned by

Trademark Operations MS-28-5A

Thousand Oaks

CA

91320-1799

Serial Number

98747390 filed on 12th Sep 2024

Registration Number

N/A

Correspondent Address

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.

Trademark Operations MS-28-5A

Thousand Oaks, CA 91320-1799

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

OXRESA

Pharmaceutical preparations; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of the gastrointestinal disorders; Pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of the gastrointestinal disorders; Pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic dermatitis, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of asthma and other breathing disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98747390

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM-2408-US-

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
14th Dec 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
14th Dec 2024NON-FINAL ACTION WRITTEN
14th Dec 2024NON-FINAL ACTION E-MAILED
28th Sep 2024ASSIGNED TO EXAMINER
12th Sep 2024NEW APPLICATION ENTERED
12th Sep 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED